<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Corral-Serrano JC</submitter><funding>Swiss National Science Foundation</funding><funding>NIHR Moorfields and UCL Institute of Ophthalmology Biomedical Research Centre</funding><funding>Moorfields Eye Charity</funding><funding>Ghent University Special Research Fund</funding><pagination>821-834</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12010153</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(9)</volume><pubmed_abstract>Inherited retinal dystrophies (IRDs) are characterized by their high clinical and genetic heterogeneity. Despite significant advances in the identification of genes associated with IRDs, many individuals and families still have not received a definite molecular diagnosis. Here, we performed clinical examinations and conducted genetic testing in five families with IRD. Whole exome sequencing in the five index cases revealed a heterozygous missense variant, c.209G > A, p.(Gly70Glu) in the ARL3 gene (NM_004311.4). A de novo occurrence was demonstrated in one affected individual and autosomal dominant inheritance in nine affected individuals from four families. Their phenotypes displayed variable expressivity, and ranged from rod-cone to cone-rod dystrophy with photophobia. Human induced pluri</pubmed_abstract><journal>Human molecular genetics</journal><pubmed_title>A novel recurrent ARL3 variant c.209G &amp;gt; A p.(Gly70Glu) causes variable non-syndromic dominant retinal dystrophy with defective lipidated protein transport in human retinal stem cell models.</pubmed_title><pmcid>PMC12010153</pmcid><funding_grant_id>176097</funding_grant_id><funding_grant_id>204285</funding_grant_id><funding_grant_id>BOF20/GOA/023</funding_grant_id><pubmed_authors>Leroy BP</pubmed_authors><pubmed_authors>Coppieters F</pubmed_authors><pubmed_authors>You Z</pubmed_authors><pubmed_authors>Corral-Serrano JC</pubmed_authors><pubmed_authors>Vaclavik V</pubmed_authors><pubmed_authors>Kaminska K</pubmed_authors><pubmed_authors>Escher P</pubmed_authors><pubmed_authors>Van de Sompele S</pubmed_authors><pubmed_authors>Cheetham ME</pubmed_authors><pubmed_authors>Van den Broeck F</pubmed_authors><pubmed_authors>Jovanovic K</pubmed_authors><pubmed_authors>Toulis V</pubmed_authors><pubmed_authors>De Baere E</pubmed_authors><pubmed_authors>Rivolta C</pubmed_authors><pubmed_authors>Tran VH</pubmed_authors><pubmed_authors>Cancellieri F</pubmed_authors><pubmed_authors>de Zaeytijd J</pubmed_authors><pubmed_authors>Quinodoz M</pubmed_authors><pubmed_authors>Bordeanu G</pubmed_authors><pubmed_authors>Ottaviani D</pubmed_authors><pubmed_authors>Hardcastle AJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>A novel recurrent ARL3 variant c.209G &amp;gt; A p.(Gly70Glu) causes variable non-syndromic dominant retinal dystrophy with defective lipidated protein transport in human retinal stem cell models.</name><description>Inherited retinal dystrophies (IRDs) are characterized by their high clinical and genetic heterogeneity. Despite significant advances in the identification of genes associated with IRDs, many individuals and families still have not received a definite molecular diagnosis. Here, we performed clinical examinations and conducted genetic testing in five families with IRD. Whole exome sequencing in the five index cases revealed a heterozygous missense variant, c.209G > A, p.(Gly70Glu) in the ARL3 gene (NM_004311.4). A de novo occurrence was demonstrated in one affected individual and autosomal dominant inheritance in nine affected individuals from four families. Their phenotypes displayed variable expressivity, and ranged from rod-cone to cone-rod dystrophy with photophobia. Human induced pluri</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2026-06-01T12:53:49.434Z</modification><creation>2025-07-03T03:05:01.787Z</creation></dates><accession>S-EPMC12010153</accession><cross_references><pubmed>40037334</pubmed><doi>10.1093/hmg/ddaf029</doi></cross_references></HashMap>